Objective: Experimental studies have shown that the prebeta-1 subclass of high-density lipoprotein particles (prebeta-1 HDL) may play an important role in the reverse cholesterol transport pathway as the initial acceptors of cellular cholesterol. The aim of the present study was the direct comparison of prebeta-1 HDL values in individuals with various types of primary dyslipidemias.
Methods: Four hundred and eighty-six unrelated individuals were included in the study. According to their lipid values study participants were subdivided into four groups: control group (n=206), type IIA dyslipidemia group (n=148), type IIB dyslipidemia group (n=49) and type IV dyslipidemia group (n=83).
Results: All dyslipidemic patients displayed higher concentrations of prebeta-1 HDL compared to control individuals. However, patients with dyslipidemias characterized by an abnormal catabolism of triglyceride-rich lipoproteins (such as dyslipidemias of type IIB and IV) tend to have higher prebeta-1 HDL values compared to patients with hypercholesterolemia, and this increase is proportional to the degree of hypertriglyceridemia. In addition, patients with metabolic syndrome exhibited significantly higher levels of prebeta-1 HDL compared to individuals that do not fulfill the criteria for the diagnosis of this syndrome. Multiple regression analysis revealed that serum triglyceride concentrations and body mass index (BMI) values were the most important determinants of prebeta-1 HDL levels in our population.
Conclusion: All dyslipidemic patients exhibit increased prebeta-1 HDL concentrations as compared to normolipidemic individuals. Whether this increase represents a defensive mechanism against atherosclerosis or it is indicative of impaired maturation of HDL particles and thus of a defective reverse cholesterol transport mechanism remains to be established.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.atherosclerosis.2009.07.038 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Relationships between HDL subpopulation proteome and HDL function in overweight/obese people with and without coronary heart disease.
Atherosclerosis
October 2024
Cardiovascular Nutrition Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA.
Background And Aims: The structure-function relationships of high-density lipoprotein (HDL) subpopulations are not well understood. Our aim was to examine the interrelationships between HDL particle proteome and HDL functionality in subjects with and without coronary heart disease (CHD).
Methods: We isolated 5 different HDL subpopulations based on charge, size, and apolipoprotein A1 (APOA1) content from the plasma of 33 overweight/obese CHD patients and 33 age-and body mass index (BMI)-matched CHD-free subjects.
High-density lipoprotein infusion therapy: A review.
J Clin Lipidol
June 2024
Division of Cardiovascular Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA (Drs Foldyna and Ghoshhajra).
Increased cholesterol-rich, low-density, non-calcified atheromas as assessed by computer coronary tomography angiography analyses have been shown to predict myocardial infarction significantly better than coronary artery calcium score or the presence of obstructive coronary artery disease (CAD) as evaluated with standard coronary angiography. Low serum high-density lipoprotein (HDL) cholesterol values are an independent risk factor for CAD. Very small, lipid-poor preβ-1 HDL particles have been shown to be most effective in promoting cellular cholesterol efflux.
View Article and Find Full Text PDFWhole-exome sequencing reveals damaging gene variants associated with hypoalphalipoproteinemia.
J Lipid Res
June 2022
Cardiovascular Research Institute, University of California, San Francisco, CA, USA; Physiological Nursing, University of California, San Francisco, CA, USA. Electronic address:
Article Synopsis
- - Low levels of HDL-C cholesterol increase the risk of heart disease, and genetic factors significantly influence HDL-C levels, as suggested by a study using whole-exome sequencing on 204 individuals with low HDL-C levels.
- - Researchers identified 120 potentially harmful gene variants in 45 candidate genes related to HDL metabolism, with the most notable being ABCA1, STAB1, and others.
- - The study highlights a strong burden of rare damaging variants in ABCA1 and LDLR genes, linking low HDL-C not only to heart disease but also possibly to cancer, pointing to new directions for research in HDL genomics.
Effect of thyroid function on pre-β1 high-density lipoprotein levels in patients with Graves' disease undergoing radioiodine treatment.
Endocrine
June 2022
Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, No.180 Fenglin Road, Shanghai, 200032, China.
Context: The metabolism of HDL is altered in thyroid dysfunctions. Preβ-1 HDL is a very small discoidal precursor HDL and promotes cholesterol efflux via ABCA. The effects of thyroid dysfunctions on pre-β1 HDL are unknown.
View Article and Find Full Text PDFThe role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.
Atherosclerosis
March 2022
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA; Boston Heart Diagnostics, Framingham, MA, USA.
Article Synopsis
- The study investigates how HDL and non-HDL parameters affect cholesterol efflux capacity (CEC) relating to coronary heart disease (CHD) and compares CHD patients with matched controls.
- It found that CHD patients had higher levels of certain HDL particles (preβ-1) and greater ABCA1-CEC, but less functional HDL compared to controls.
- The research indicates that triglyceride-rich lipoproteins significantly impact both the concentration and functionality of HDL particles and cholesterol efflux in CHD patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!